The European Medicines Agency and the US Food and Drug Administration came to the same decision for over 90% of 107 marketing authorization applications between 2014 and 2016, a first-of-a-kind study conducted by both regulators has shown.
Concordance between the EMA and the FDA was high at 91% for initial decisions on marketing approvals, and even higher...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?